InnovAge Holding Corp. (INNV)
USD 2.91
(5.43%)
USD 2.91
(5.43%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 100.49 Million USD | -5.19% |
| 2023 | 96.78 Million USD | 24.64% |
| 2022 | 77.65 Million USD | 1.15% |
| 2021 | 76.76 Million USD | -64.22% |
| 2020 | 214.52 Million USD | 12.23% |
| 2019 | 191.14 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 100.49 Million USD | -1.35% |
| 2024 Q3 | 62.32 Million USD | -1.33% |
| 2024 Q2 | 100.41 Million USD | -1.31% |
| 2024 FY | 100.49 Million USD | 3.83% |
| 2024 Q1 | 94.13 Million USD | -1.3% |
| 2023 Q3 | 99.17 Million USD | 3.75% |
| 2023 Q2 | 95.59 Million USD | -1.33% |
| 2023 FY | 96.78 Million USD | 24.64% |
| 2023 Q1 | 96.88 Million USD | 24.77% |
| 2023 Q4 | 96.78 Million USD | -2.41% |
| 2022 Q2 | 78.68 Million USD | 4.22% |
| 2022 Q4 | 77.65 Million USD | -2.12% |
| 2022 Q3 | 79.33 Million USD | 0.83% |
| 2022 Q1 | 75.49 Million USD | -1.65% |
| 2022 FY | 77.65 Million USD | 1.15% |
| 2021 Q2 | 296.07 Million USD | 0.0% |
| 2021 FY | 76.76 Million USD | -64.22% |
| 2021 Q4 | 76.76 Million USD | -1.76% |
| 2021 Q3 | 78.14 Million USD | -73.61% |
| 2020 Q4 | 214.52 Million USD | 0.0% |
| 2020 FY | 214.52 Million USD | 12.23% |
| 2019 FY | 191.14 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 92.515% |
| Addus HomeCare Corporation | 124.13 Million USD | 19.041% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -44.592% |
| Amedisys, Inc. | 346.76 Million USD | 71.019% |
| American Oncology Network, Inc. | 120.44 Million USD | 16.562% |
| Astrana Health, Inc. | 296.26 Million USD | 66.079% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 92.126% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | 5.753% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -982.701% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -3673.789% |
| COMPASS Pathways plc | 28.75 Million USD | -249.466% |
| DocGo Inc. | 15.16 Million USD | -562.818% |
| The Ensign Group, Inc. | 1.78 Billion USD | 94.369% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -794.49% |
| Assure Holdings Corp. | 505 Thousand USD | -19800.198% |
| The Joint Corp. | 2 Million USD | -4924.8% |
| LifeStance Health Group, Inc. | 280.28 Million USD | 64.145% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -26246.546% |
| ModivCare Inc. | 983.75 Million USD | 89.784% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -84365.326% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -5614.497% |
| Option Care Health, Inc. | 1.05 Billion USD | 90.489% |
| P3 Health Partners Inc. | 108.31 Million USD | 7.222% |
| P3 Health Partners Inc. | 108.31 Million USD | 7.222% |
| The Pennant Group, Inc. | 312.51 Million USD | 67.842% |
| Surgery Partners, Inc. | 2.03 Billion USD | 95.058% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -15.744% |
| The Oncology Institute, Inc. | 86.82 Million USD | -15.744% |